Drug safety signal explorer

Find the adverse events that FDA labels don't mention.

Millions of adverse-event reports reach the FDA every year. This site runs the same disproportionality statistics that drug-safety teams use on the FDA Adverse Event Reporting System (FAERS). It shows which reactions are reported unusually often for a drug, and which of them its label doesn't mention.

Rank every drug–reaction pair

Each pair is scored with the reporting odds ratio (ROR) and the Bayesian information component (IC). The lower confidence bound keeps rare, noisy pairs from crowding out real signals.

Skip what's already known

Hide reactions already documented in the drug's FDA labeling, and reactions that are really the condition the drug treats. What's left is the unexpected.

Zoom in or out

Look at individual MedDRA preferred terms, or roll them up into broader term groups. Filter by body system, outcome severity, report count, brand vs. generic, and commonly prescribed drugs.

Try the demo

The demo has the full search and every filter, but it covers FAERS reports received before 2019 only. More recent reports are part of the full version.

Access is by invitation. Enter the access code you were given.

A reporting signal is a lead to investigate, not proof that a drug causes a reaction. FAERS reports are voluntary and unverified, and they can't be used to estimate how often a reaction happens.


Data on this site are drawn from the U.S. Food and Drug Administration's Adverse Event Reporting System (FAERS) quarterly data files for 2018 Q1–Q4, 2023 Q1, and 2024 Q1 – 2026 Q1, limited to cases the FDA first received in 2019 or later.

For any given report, there is no certainty that a suspected drug caused the reaction. Accumulated reports cannot be used to calculate occurrence rates or to estimate drug risk. Comparisons between drugs cannot be made from these data.


Copyright 2026